Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03586102
Other study ID # 300000681
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date August 23, 2018
Est. completion date December 2024

Study information

Verified date December 2023
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study hypothesis is that, in human milk-fed extremely preterm infants, higher protein intake compared to usual protein intake reduces percent body fat (%BF) at 3 months of age.


Description:

Qualifying participants will be randomly assigned to receive either standard protein supplementation (control group) or high protein supplementation (intervention group). Intervention group: A fixed amount of commercially available hydrolyzed bovine protein will be added to fortified human milk after establishment of full enteral feeding. Control group: Hydrolyzed bovine protein will not be added to fortified human milk after establishment of full enteral feeding. If parent agrees, stool "dirty" diapers will be collected 2 times (at the time of hospital discharge and at 3 months of corrected age).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 56
Est. completion date December 2024
Est. primary completion date April 30, 2020
Accepts healthy volunteers No
Gender All
Age group 1 Day to 21 Days
Eligibility Inclusion Criteria: - Gestational age between 25 and 28 weeks of gestation - Feeding volumes of =120 ml/kg/day before or on postnatal day 14. Exclusion Criteria: - Necrotizing enterocolitis (NEC) stage 2 or greater. - Gastrointestinal or neurologic malformations. - Terminal illness needing to limit or withhold support will be exclusion criteria.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
High protein supplementation
To increase protein content of human milk, a fixed amount of commercially available hydrolyzed bovine protein will be added to fortified human milk. With this pragmatic approach, preterm infants assigned to the high protein supplementation group will receive > 4.5 g/kg/day of enteral protein after establishment of full enteral feeding.
Standard protein supplementation
Infants assigned to the standard protein supplementation group will receive fortified human milk (< 4.5 g/kg/day of enteral protein)

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham Children's Health System, Alabama

Country where clinical trial is conducted

United States, 

References & Publications (1)

Salas AA, Jerome M, Finck A, Razzaghy J, Chandler-Laney P, Carlo WA. Body composition of extremely preterm infants fed protein-enriched, fortified milk: a randomized trial. Pediatr Res. 2022 Apr;91(5):1231-1237. doi: 10.1038/s41390-021-01628-x. Epub 2021 Jun 28. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Changes in intestinal microbiome Determined by molecular analyses of bacteria in fecal samples Birth to 3 months of corrected age
Other Changes in metabolic pathways Determined by molecular analyses of serum samples Birth to 3 months of corrected age
Primary Infant body composition Percent body fat estimated by air displacement plethysmography Assessed at 36 weeks of postmenstrual age or at 3 months of corrected age
Secondary Infant body composition Percent body fat estimated by air displacement plethysmography Assessed at 36 weeks of postmenstrual age or hospital discharge (whichever occurs first)
Secondary Growth Weekly weight gain in grams Birth to 3 months of corrected age
Secondary Length Weekly length in cm Birth to 3 months of corrected age
Secondary Head circumference Weekly head circumference in cm Birth to 3 months of corrected age
Secondary Body mass index Weight and height will be combined to report BMI in kg/m^2 Birth to 3 months of corrected age
Secondary Necrotizing enterocolitis Number of participants with diagnosis of necrotizing enterocolitis stage 2 or 3 Postnatal day 14 to postnatal day 120 or discharge, whichever occurs first
Secondary Death Postnatal day 14 to postnatal day 120 or discharge, whichever occurs first
See also
  Status Clinical Trial Phase
Terminated NCT02550054 - Erythropoietin in Premature Infants to Prevent Encephalopathy Phase 2
Completed NCT03827252 - Respiratory Stability and Vegetative Coupling During Neonatal Skin-to-skin Care
Active, not recruiting NCT03345069 - Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
Completed NCT04067206 - The Effects Of Auditory Interventions On Pain And Comfort In Premature Infants N/A
Completed NCT03911674 - Effects of Oral Stimulation in Preterm Infants Phase 3
Completed NCT03324126 - Individualized Fortification of Breast Milk N/A
Completed NCT03704012 - Efficacy of Massage Applied by the Parents in Hospitalized Premature Birth (PreMas) N/A
Active, not recruiting NCT03241082 - Ultrasound Assessment of BC in the NICU
Completed NCT03701906 - Effect of a Mixture of New Probiotic Strains in Preterm Infants N/A
Completed NCT02133716 - Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm Phase 4
Not yet recruiting NCT05543005 - Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants N/A
Recruiting NCT03852641 - Feeding Premature Infants During Non-invasive Respiratory Support N/A
Active, not recruiting NCT03423914 - Efficacy of Expressive Writing in Mothers of Preterm Infants N/A
Recruiting NCT04648787 - A Study of Family-integrated Care for Reducing Uncertainty N/A
Recruiting NCT04866342 - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor N/A
Not yet recruiting NCT02534090 - Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy N/A
Not yet recruiting NCT02601872 - Erythropoietin in Premature Infants to Prevent Encephalopathy Phase 2
Recruiting NCT06212427 - Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs) N/A
Suspended NCT03939169 - The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP) N/A
Completed NCT03726697 - Effect of Tahneek on Hypoglycemia in Newborn Infants N/A